NCT04558385View on ClinicalTrials.gov

Seroconversion in COVID-19 Recovered Population

CompletedOBSERVATIONAL
Enrollment

275

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

IgG SARS CoV2

IgG SARS CoV 2 will be checked in serum of COVID 19 recovered population

Trial Locations (1)

54500

Lahore General Hospital, Lahore

All Listed Sponsors
lead

Lahore General Hospital

OTHER_GOV

NCT04558385 - Seroconversion in COVID-19 Recovered Population | Biotech Hunter | Biotech Hunter